Case Distillery
BLOG · ISSUE #022

How a Mobile IV Therapy Business Hit $250K/mo in 90 Days

Jul 18, 2026·2 min read

The drip is what's on the invoice. The moat is somewhere else entirely, and it's not what most operators trying to copy this mobile IV therapy business will ever notice.

The case at a glance

Third company, ninety days in. The operator ran the same playbook three times: $0→$2M in year one on company #1, $2.4M→$10M as CEO of company #2, then this one launched April 2026. Post-Jenifer's-Law (Texas, Sept 2025) just raised the compliance floor for everyone behind him. He's already inside.

Stack: PLLC foreign-registered into 8 states, MD-owned entity, NP-led telehealth Good Faith Exam, 503B compounding pharmacy, HIPAA EHR, Square, Google Business Profile as the primary funnel, SMS reactivation on a 4–6 week cadence.

What this mobile IV startup is actually selling

The product isn't the Myers cocktail. The product is the hour — the 60 to 90 minutes between "I feel like garbage" and "I'm functional." Everything on the menu is inventory dressed up as a category.

That reframe is why he's already telling on himself: he wants to cut from 30+ formulations down to 8 top sellers. If you're copying this, that's step one, not step ten. You aren't a compounding pharmacy. You're a same-day rescue service that happens to use IVs.

The second thing most people miss: the 50/50 nurse split isn't standard. In his version, the nurse absorbs supply cost and card-processing fees. His marginal cost per booking is close to zero. Every incremental drip is contribution margin, which is the only reason $250K/mo at day 90 is a coherent sentence.

Zero-marginal-cost service businesses are rarer than they look. Most operators running the standard 60/40 stall at $50K/mo because scaling adds variable pain. He bet on a structure where growth doesn't cost him more, and that single decision separates a $250K month from a $50K ceiling.

Want the full dissection?

This is the free preview. The full paid issue covers the four moves in the order they detonated, the pricing leash math, a 5-step replication playbook, and why cold launches don't work in 2026.

Read Issue #022 in full → First 100 subscribers lock $99/yr forever. After that it moves to the standard tier.